Cited by

• Biofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer's disease in vitro.

  Yang CC, Yang SY, Chieh JJ, Horng HE, Hong CY, Yang HC, Chen KH, Shih BY, Chen TF, Chiu MJ. Yang CC, et al. ACS Chem Neurosci. 2011 Sep 21;2(9):500-5. doi: 10.1021/cn200028j. Epub 2011 May 30. ACS Chem Neurosci. 2011. PMID: 22860173 Free PMC article.
• Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment.

  Blennow K, De Meyer G, Hansson O, Minthon L, Wallin A, Zetterberg H, Lewczuk P, Vanderstichele H, Vanmechelen E, Kornhuber J, Wiltfang J; KND-Study Group; Heuser I, Maier W, Luckhaus C, Rüther E, Hüll M, Jahn H, Gertz HJ, Frölich L, Hampel H, Pernetzki R. Blennow K, et al. J Nutr Health Aging. 2009 Mar;13(3):205-8. doi: 10.1007/s12603-009-0059-0. J Nutr Health Aging. 2009. PMID: 19262954
• Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease.

  Villemagne VL, Perez KA, Pike KE, Kok WM, Rowe CC, White AR, Bourgeat P, Salvado O, Bedo J, Hutton CA, Faux NG, Masters CL, Barnham KJ. Villemagne VL, et al. J Neurosci. 2010 May 5;30(18):6315-22. doi: 10.1523/JNEUROSCI.5180-09.2010. J Neurosci. 2010. PMID: 20445057 Free PMC article.
• Amyloid-associated depression: a prodromal depression of Alzheimer disease?

  Sun X, Steffens DC, Au R, Folstein M, Summergrad P, Yee J, Rosenberg I, Mwamburi DM, Qiu WQ. Sun X, et al. Arch Gen Psychiatry. 2008 May;65(5):542-50. doi: 10.1001/archpsyc.65.5.542. Arch Gen Psychiatry. 2008. PMID: 18458206 Free PMC article.
• An amylin analog used as a challenge test for Alzheimer's disease.

  Zhu H, Stern RA, Tao Q, Bourlas A, Essis MD, Chivukula M, Rosenzweig J, Steenkamp D, Xia W, Mercier GA, Tripodis Y, Farlow M, Kowall N, Qiu WQ. Zhu H, et al. Alzheimers Dement (N Y). 2017 Jan;3(1):33-43. doi: 10.1016/j.trci.2016.12.002. Alzheimers Dement (N Y). 2017. PMID: 28503657 Free PMC article.